UBX1325, a small molecule inhibitor of Bcl-xL, attenuates vascular dysfunction in two animal models of retinopathy

/in /by

https://www.nature.com/articles/s41591-024-02802-4

You might also like
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition
Cellular Senescence Is Associated With Human Retinal Microaneurysm Formation During Aging

©2024 Unity Biotechnology. All Rights Reserved. Terms & Conditions | Privacy Policy

Pathological angiogenesis in retinopathy engages cellular senescence and is...Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical...